Thomas Roos

Thomas Roos is a multifaceted individual with a background in science, athletics, and entrepreneurship. He is currently associated with the organization "5 Ironmans Beat Alzheimer's" as the Head of Sports & Science.1

Professional Background

Thomas Roos has a diverse professional profile that combines scientific expertise with athletic achievements:

• Scientist: He is involved in scientific research and projects.2
• Entrepreneur: Roos is engaged in entrepreneurial activities, particularly in the field of sports genomics.2
• Sports Genomics: His work appears to focus on the intersection of genetics and sports performance.2

Athletic Achievements

Thomas Roos is an accomplished athlete with a strong background in triathlon:

• Ironman Competitor: As evident from his association with "5 Ironmans Beat Alzheimer's," he has experience with Ironman triathlons.1
• Stanford Triathlon Team: During his time at Stanford, Roos was an active member of the university's triathlon team.1
• Leadership Roles: He held several positions within the Stanford Triathlon team, including:
  • Vice-President (3 years)
  • Social Chair (1 year)
  • Safety Chair (1 year)
  • Nationals Team member1

Recent Activities

Thomas Roos has been involved in various initiatives combining his interests in sports, science, and philanthropy:

• He recently announced the launch of a scientific side-project in collaboration with Hassan's foundation, which involves a triathlon challenge.3
• Roos is actively engaged in promoting high-performance sports and related scientific research.2

Entrepreneurial Ventures

While not explicitly mentioned in the provided search results, it's worth noting that Thomas Roos is reported to be the co-Founder and CEO of GeneLook, a company likely related to his work in sports genomics.4

Thomas Roos's unique combination of scientific expertise, athletic prowess, and entrepreneurial spirit positions him as a notable figure in the intersection of sports science, genomics, and philanthropic efforts to combat Alzheimer's disease.